Showing results (171-180 of 208) with videos related to
Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1992
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtypeG McAllister, A Charlesworth, C Snodin, et al.Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophreniaN I Perrone-Bizzozero, A C Sower, E D Bird, et al.Annals of Neurology|November 11, 1991
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological studyJ P Vonsattel, R H Myers, E T Hedley-Whyte, et al.Lancet (London, England)|January 29, 1983
Maternal transmission in Huntington's diseaseR H Myers, D Goldman, E D Bird, et al.Journal of Neurochemistry|June 1, 1982
Regional distribution of neurotensin in human brainP J Manberg, W W Youngblood, C B Nemeroff, et al.Annals of Neurology|May 1, 1983
Somatostatin is increased in the basal ganglia in Huntington diseaseN Aronin, P E Cooper, L J Lorenz, et al.Annals of Neurology|June 1, 1988
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's diseaseM F Beal, M F Mazurek, D W Ellison, et al.Peptide Research|July 1, 1992
Somatostatin-gene expression in the postmortem adult and fetal human brainE G Stopa, G R Uhl, B F O'Hara, et al.Synapse (New York, N.Y.)|December 1, 1994
Alterations in TRH receptors in temporal lobe of schizophrenics: a quantitative autoradiographic studyN Lexow, J N Joyce, S J Kim, et al.Journal of the Neurological Sciences|March 1, 1988
A detailed examination of substance P in pathologically graded cases of Huntington's diseaseM F Beal, D W Ellison, M F Mazurek, et al.Pageof 21